Daré Bioscience (DARE) Financial Statements

1,880 Followers

Daré Bioscience Financial Overview

Daré Bioscience's market cap is currently $26.64M. The company's EPS TTM is $0.03; its P/E ratio is -16.10; Daré Bioscience is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	$ 1.03M	$ 9.78K	$ 2.81M	$ 10.00M	$ 0.00
Gross Profit	$ -1.42M	$ -14.30M	$ -18.83M	$ -20.14M	$ -100.00K
Operating Income	$ -13.55M	$ -23.45M	$ -30.94M	$ -31.39M	$ -39.07M
EBITDA	$ -11.40M	$ -23.41M	$ -30.70M	$ -31.36M	$ -39.04M
Net Income	$ -13.40M	$ -4.05M	$ -30.16M	$ -30.95M	$ -38.70M
Balance Sheet
Cash & Short-Term Investments	$ 24.71B	$ 15.70M	$ 10.48M	$ 34.67M	$ 51.67M
Total Assets	$ 32.47M	$ 22.10M	$ 21.28M	$ 43.83M	$ 55.81M
Total Debt	$ 2.66B	$ 1.30M	$ 1.40M	$ 488.74K	$ 270.55K
Net Debt	$ -22.06B	$ -14.40M	$ -9.07M	$ -34.18M	$ -51.40M
Total Liabilities	$ 29.63M	$ 28.11M	$ 26.33M	$ 32.71M	$ 17.05M
Stockholders' Equity	$ 2.84M	$ -6.01M	$ -5.05M	$ 11.11M	$ 38.75M
Cash Flow
Free Cash Flow	$ -10.27B	$ 4.82M	$ -39.49M	$ -18.15M	$ -28.78M
Operating Cash Flow	$ -9.89B	$ 5.39M	$ -38.86M	$ -18.09M	$ -28.76M
Investing Cash Flow	$ -385.28M	$ -573.05K	$ -629.43K	$ -63.07K	$ -14.52K
Financing Cash Flow	$ 19.28B	$ 433.83K	$ 15.64M	$ 1.34M	$ 75.85M

Currency in USD

Daré Bioscience Earnings and Revenue History

Income Statement >

Daré Bioscience Debt to Assets

Balance Sheet >

Daré Bioscience Cash Flow

Cash Flow >

Daré Bioscience Forecast EPS vs Actual EPS

Earnings >